IL-4 AND IL-13 INDUCE LSK, A CSK-LIKE TYROSINE KINASE, IN HUMAN MONOCYTES

被引:27
|
作者
MUSSO, T
VARESIO, L
ZHANG, XY
ROWE, TK
FERRARA, P
ORTALDO, JR
OSHEA, JJ
MCVICAR, DW
机构
[1] NCI,FREDERICK CANC RES & DEV CTR,MACROPHAGE CELL BIOL SECT,EXPTL IMMUNOL LAB,FREDERICK,MD 21702
[2] SANOFI ELF BIO RECH,F-31676 LABEGE,FRANCE
来源
JOURNAL OF EXPERIMENTAL MEDICINE | 1994年 / 180卷 / 06期
关键词
D O I
10.1084/jem.180.6.2383
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Lsk is a protein tyrosine kinase with homology to the COOH-terminal Src kinase (Csk). Unlike Csk that is ubiquitously expressed, Lsk has limited tissue distribution. Here we have examined the expression and regulation of Lsk and Csk in peripheral human monocytes. We have found that Lsk mRNA and protein were not expressed in resting monocytes but were induced by treatment with interleukin 4 (IL-4) or IL-13 but not by interferon gamma (IFN-gamma) or IL-2. In fact, IFN-gamma, but not IL-2, efficiently blocked Lsk induction by IL-4 or IL-13. In contrast, Csk was constitutively present in human monocytes and was upregulated by IFN-gamma but not by IL-4 or IL-13. These results suggest that despite their structural similarities, Lsk and Csk may play distinct regulatory roles in monocyte functions elicited by cytokines, with Lsk functioning specifically within the context of a Th2-type immune response.
引用
收藏
页码:2383 / 2388
页数:6
相关论文
共 50 条
  • [31] IL-21 effects on human IgE production in response to IL-4 or IL-13
    Wood, N
    Bourque, K
    Donaldson, DD
    Collins, M
    Vercelli, D
    Goldman, SJ
    Kasaian, MT
    CELLULAR IMMUNOLOGY, 2004, 231 (1-2) : 133 - 145
  • [32] IL-4 and IL-13, but not IL-10, protect human synoviocytes from apoptosis
    Relic, B
    Guicheux, J
    Mezin, F
    Lubberts, E
    Togninalli, D
    Garcia, I
    van den Berg, WB
    Guerne, PA
    JOURNAL OF IMMUNOLOGY, 2001, 166 (04): : 2775 - 2782
  • [33] Characterization of IL-4 and IL-13 signals dependent on the human IL-13 receptor α chain 1:: redundancy of requirement of tyrosine residue for STAT3 activation
    Umeshita-Suyama, R
    Sugimoto, R
    Akaiwa, M
    Arima, K
    Yu, B
    Wada, M
    Kuwano, M
    Nakajima, K
    Hamasaki, N
    Izuhara, K
    INTERNATIONAL IMMUNOLOGY, 2000, 12 (11) : 1499 - 1509
  • [34] Targeting of IL-4 and IL-13 receptors for cancer therapy
    Suzuki, Akiko
    Leland, Pamela
    Joshi, Bharat H.
    Puri, Raj K.
    CYTOKINE, 2015, 75 (01) : 79 - 88
  • [35] Distinct signal requirement for IL-4 and IL-13 expression
    Keen, JC
    Natarajan, S
    Burke, T
    Guo, J
    Cianferoni, A
    Schmidt, J
    Casolaro, V
    Wills-Karp, M
    Georas, SN
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2001, 107 (02) : S148 - S148
  • [36] IL-4 and IL-13 signaling in allergic airway disease
    Gour, Naina
    Wills-Karp, Marsha
    CYTOKINE, 2015, 75 (01) : 68 - 78
  • [37] Mast cell production and response to IL-4 and IL-13
    McLeod, Jamie J. A.
    Baker, Bianca
    Ryan, John J.
    CYTOKINE, 2015, 75 (01) : 57 - 61
  • [38] Roles of IL-4, IL-13, and Their Receptors in Lung Cancer
    Zhang, Yao
    Zhu, Kangle
    Wang, Xiao
    Zhao, Yi
    Shi, Jingwei
    Liu, Zhengcheng
    JOURNAL OF INTERFERON AND CYTOKINE RESEARCH, 2024, 44 (09): : 399 - 407
  • [39] Differential signaling to IL-4 and IL-13 in allergic disease
    Heller, Nicola Mary
    Qi, Xiulan
    Keegan, Achsah D.
    JOURNAL OF IMMUNOLOGY, 2006, 176 : S24 - S24
  • [40] Commonality of the IL-4/IL-13 pathway in atopic diseases
    Gandhi, Namita A.
    Pirozzi, Gianluca
    Graham, Neil M. H.
    EXPERT REVIEW OF CLINICAL IMMUNOLOGY, 2017, 13 (05) : 425 - 437